Cool-To The Moon - Tiger Brokers Online Investing Community - To The Moon

1
Comment
Favorite

GoldStar66
09-15

Cool

How This ASX All Ords Stock Transformed A $10,000 Investment Into $76,521 Within 2 Months

The All Ordinaries Index (ASX: XAO) has risen 4.0% since the market closed on 9 July, but one particular ASX All Ords stock has significantly outpaced this growth.The stock in question is 4DMedical...

How This ASX All Ords Stock Transformed A $10,000 Investment Into $76,521 Within 2 Months

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

1

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":478826144735368,"tweetId":"478826144735368","gmtCreate":1757921573733,"gmtModify":1757922500865,"author":{"id":4213226557592442,"idStr":"4213226557592442","authorId":4213226557592442,"authorIdStr":"4213226557592442","name":"GoldStar66","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>Cool</p></body></html>","htmlText":"<html><head></head><body><p>Cool</p></body></html>","text":"Cool","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/478826144735368","repostId":1138598192,"repostType":2,"repost":{"id":"1138598192","kind":"news","weMediaInfo":{"introduction":"Go Trading Go","home_visible":1,"media_name":"Trading Random","id":"1081967000","head_image":"https://community-static.tradeup.com/news/c47c5e15a11ec5cf40edd30d2c7cf544"},"pubTimestamp":1757905920,"share":"https://ttm.financial/m/news/1138598192?lang=en_US&edition=fundamental","pubTime":"2025-09-15 11:12","language":"en","title":"How This ASX All Ords Stock Transformed A $10,000 Investment Into $76,521 Within 2 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=1138598192","media":"Trading Random","summary":"The All Ordinaries Index (ASX: XAO) has risen 4.0% since the market closed on 9 July, but one particular ASX All Ords stock has significantly outpaced this growth.The stock in question is 4DMedical...","content":"<html><head></head><body><p>The <strong>All Ordinaries Index</strong> (ASX: XAO) has risen 4.0% since the market closed on 9 July, but one particular ASX All Ords stock has significantly outpaced this growth.</p><p style=\"text-align: start;\">The stock in question is <strong>4DMedical Ltd</strong> (ASX: 4DX), a company specializing in respiratory imaging technology.</p><h2 id=\"id_2046335161\" style=\"text-align: start;\">ASX All Ords stock on a ten-bagger trajectory</h2><p style=\"text-align: start;\">A ten-bagger refers to a stock that grows tenfold from its original investment within a specific period.</p><p style=\"text-align: start;\">Although the 4DMedical&#39;s share price hasn&#39;t yet increased by 1,000% (and it may not reach that level), the company has certainly pleased its investors over the past two months.</p><p style=\"text-align: start;\">How pleased?</p><p style=\"text-align: start;\">Well, on 9 July, shares of the ASX All Ords stock were available for 23 cents each.</p><p style=\"text-align: start;\">With a $10,000 investment, you could have acquired 43,478 shares of 4DMedical.</p><p style=\"text-align: start;\">As of Friday, those shares were trading at $1.76 each.</p><p style=\"text-align: start;\">This represents a remarkable gain of 665%.</p><p style=\"text-align: start;\">Consequently, your $10,000 investment would have grown to $76,521.</p><p style=\"text-align: start;\">In a mere two months!</p><p style=\"text-align: start;\">Here’s what has been propelling the company’s rise.</p><h2 id=\"id_3917967861\" style=\"text-align: start;\">What fueled 4DMedical&#39;s 665% surge?</h2><p style=\"text-align: start;\">4DMedical has announced several successes in the past two months that have significantly captured investor interest.</p><p style=\"text-align: start;\">Focusing on the major highlights, on 1 August, shares in the ASX All Ords stock increased by 27.1% following the company&#39;s announcement of a $10 million investment from health imaging giant <strong>Pro Medicus Ltd</strong> (ASX: PME).</p><p style=\"text-align: start;\">On that day, 4DMedical CEO Andreas Fouras commented on Pro Medicus&#39;s investment:</p><blockquote><p>Pro Medicus is a global leader in healthcare, and we are thrilled to receive their support at this pivotal moment in our journey. This strategic investment positions us strongly to bring CT:VQ to market once it obtains FDA clearance.</p></blockquote><p style=\"text-align: start;\">CT:VQ refers to the company&#39;s CAT scan-based ventilation-perfusion software.</p><p style=\"text-align: start;\">Fast-forward to September, and shares in the ASX All Ords stock surged 36.0% on 1 September after the company announced it had received FDA clearance for CT:VQ.</p><p style=\"text-align: start;\">Just two days later, on 3 September, shares surged another 50.0%.</p><p style=\"text-align: start;\">This substantial intraday gain occurred after 4DMedical revealed that the US Centers for Medicare &amp; Medicaid Services (CMS) confirmed reimbursement for CT:VQ, with payments of US$650.50 per scan, effective from early September.</p><p style=\"text-align: start;\">And on Monday, 8 September, the ASX All Ords stock closed up an additional 49.5%.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>How This ASX All Ords Stock Transformed A $10,000 Investment Into $76,521 Within 2 Months</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHow This ASX All Ords Stock Transformed A $10,000 Investment Into $76,521 Within 2 Months\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1081967000\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/c47c5e15a11ec5cf40edd30d2c7cf544);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Trading Random </p>\n<p class=\"h-time\">2025-09-15 11:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>The <strong>All Ordinaries Index</strong> (ASX: XAO) has risen 4.0% since the market closed on 9 July, but one particular ASX All Ords stock has significantly outpaced this growth.</p><p style=\"text-align: start;\">The stock in question is <strong>4DMedical Ltd</strong> (ASX: 4DX), a company specializing in respiratory imaging technology.</p><h2 id=\"id_2046335161\" style=\"text-align: start;\">ASX All Ords stock on a ten-bagger trajectory</h2><p style=\"text-align: start;\">A ten-bagger refers to a stock that grows tenfold from its original investment within a specific period.</p><p style=\"text-align: start;\">Although the 4DMedical&#39;s share price hasn&#39;t yet increased by 1,000% (and it may not reach that level), the company has certainly pleased its investors over the past two months.</p><p style=\"text-align: start;\">How pleased?</p><p style=\"text-align: start;\">Well, on 9 July, shares of the ASX All Ords stock were available for 23 cents each.</p><p style=\"text-align: start;\">With a $10,000 investment, you could have acquired 43,478 shares of 4DMedical.</p><p style=\"text-align: start;\">As of Friday, those shares were trading at $1.76 each.</p><p style=\"text-align: start;\">This represents a remarkable gain of 665%.</p><p style=\"text-align: start;\">Consequently, your $10,000 investment would have grown to $76,521.</p><p style=\"text-align: start;\">In a mere two months!</p><p style=\"text-align: start;\">Here’s what has been propelling the company’s rise.</p><h2 id=\"id_3917967861\" style=\"text-align: start;\">What fueled 4DMedical&#39;s 665% surge?</h2><p style=\"text-align: start;\">4DMedical has announced several successes in the past two months that have significantly captured investor interest.</p><p style=\"text-align: start;\">Focusing on the major highlights, on 1 August, shares in the ASX All Ords stock increased by 27.1% following the company&#39;s announcement of a $10 million investment from health imaging giant <strong>Pro Medicus Ltd</strong> (ASX: PME).</p><p style=\"text-align: start;\">On that day, 4DMedical CEO Andreas Fouras commented on Pro Medicus&#39;s investment:</p><blockquote><p>Pro Medicus is a global leader in healthcare, and we are thrilled to receive their support at this pivotal moment in our journey. This strategic investment positions us strongly to bring CT:VQ to market once it obtains FDA clearance.</p></blockquote><p style=\"text-align: start;\">CT:VQ refers to the company&#39;s CAT scan-based ventilation-perfusion software.</p><p style=\"text-align: start;\">Fast-forward to September, and shares in the ASX All Ords stock surged 36.0% on 1 September after the company announced it had received FDA clearance for CT:VQ.</p><p style=\"text-align: start;\">Just two days later, on 3 September, shares surged another 50.0%.</p><p style=\"text-align: start;\">This substantial intraday gain occurred after 4DMedical revealed that the US Centers for Medicare &amp; Medicaid Services (CMS) confirmed reimbursement for CT:VQ, with payments of US$650.50 per scan, effective from early September.</p><p style=\"text-align: start;\">And on Monday, 8 September, the ASX All Ords stock closed up an additional 49.5%.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"4DX.AU":"4DMEDICAL LTD"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138598192","content_text":"The All Ordinaries Index (ASX: XAO) has risen 4.0% since the market closed on 9 July, but one particular ASX All Ords stock has significantly outpaced this growth.The stock in question is 4DMedical Ltd (ASX: 4DX), a company specializing in respiratory imaging technology.ASX All Ords stock on a ten-bagger trajectoryA ten-bagger refers to a stock that grows tenfold from its original investment within a specific period.Although the 4DMedical's share price hasn't yet increased by 1,000% (and it may not reach that level), the company has certainly pleased its investors over the past two months.How pleased?Well, on 9 July, shares of the ASX All Ords stock were available for 23 cents each.With a $10,000 investment, you could have acquired 43,478 shares of 4DMedical.As of Friday, those shares were trading at $1.76 each.This represents a remarkable gain of 665%.Consequently, your $10,000 investment would have grown to $76,521.In a mere two months!Here’s what has been propelling the company’s rise.What fueled 4DMedical's 665% surge?4DMedical has announced several successes in the past two months that have significantly captured investor interest.Focusing on the major highlights, on 1 August, shares in the ASX All Ords stock increased by 27.1% following the company's announcement of a $10 million investment from health imaging giant Pro Medicus Ltd (ASX: PME).On that day, 4DMedical CEO Andreas Fouras commented on Pro Medicus's investment:Pro Medicus is a global leader in healthcare, and we are thrilled to receive their support at this pivotal moment in our journey. This strategic investment positions us strongly to bring CT:VQ to market once it obtains FDA clearance.CT:VQ refers to the company's CAT scan-based ventilation-perfusion software.Fast-forward to September, and shares in the ASX All Ords stock surged 36.0% on 1 September after the company announced it had received FDA clearance for CT:VQ.Just two days later, on 3 September, shares surged another 50.0%.This substantial intraday gain occurred after 4DMedical revealed that the US Centers for Medicare & Medicaid Services (CMS) confirmed reimbursement for CT:VQ, with payments of US$650.50 per scan, effective from early September.And on Monday, 8 September, the ASX All Ords stock closed up an additional 49.5%.","news_type":1,"symbols_score_info":{"4DX.AU":1.1}},"isVote":1,"tweetType":1,"viewCount":406,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}